LGL Group (NYSEAMERICAN:LGL) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

LGL Group, Inc. (The) (NYSEAMERICAN:LGL) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.01 and traded as high as $7.15. LGL Group shares last traded at $7.15, with a volume of 23,453 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised LGL Group to a “hold” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

LGL Group Stock Performance

The business’s 50 day moving average is $6.92 and its 200-day moving average is $7.02. The firm has a market capitalization of $47.74 million, a price-to-earnings ratio of 730.73 and a beta of 0.32.

Institutional Trading of LGL Group

Several hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. grew its holdings in LGL Group by 15.5% in the 2nd quarter. Osaic Holdings Inc. now owns 20,250 shares of the industrial products company’s stock valued at $154,000 after buying an additional 2,710 shares during the last quarter. Citadel Advisors LLC acquired a new position in shares of LGL Group during the third quarter worth approximately $90,000. Gamco Investors INC. ET AL boosted its position in shares of LGL Group by 2.8% in the first quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company’s stock valued at $4,662,000 after acquiring an additional 18,305 shares during the period. Finally, Renaissance Technologies LLC boosted its position in shares of LGL Group by 3.6% in the first quarter. Renaissance Technologies LLC now owns 166,594 shares of the industrial products company’s stock valued at $1,158,000 after acquiring an additional 5,773 shares during the period. Institutional investors own 30.28% of the company’s stock.

About LGL Group

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.